Booster COVID-19 Vaccinations Among Persons Aged ≥5 Years and Second Booster COVID-19 Vaccinations Among Persons Aged ≥50 Years - United States, August 13, 2021-August 5, 2022.
作者信息
Fast Hannah E, Murthy Bhavini Patel, Zell Elizabeth, Meng Lu, Murthy Neil, Saelee Ryan, Lu Peng-Jun, Kang Yoonjae, Shaw Lauren, Gibbs-Scharf Lynn, Harris LaTreace
出版信息
MMWR Morb Mortal Wkly Rep. 2022 Sep 2;71(35):1121-1125. doi: 10.15585/mmwr.mm7135a4.
Abstract
摘要
相似文献
1
Booster COVID-19 Vaccinations Among Persons Aged ≥5 Years and Second Booster COVID-19 Vaccinations Among Persons Aged ≥50 Years - United States, August 13, 2021-August 5, 2022.≥5岁人群的新冠病毒加强疫苗接种及≥50岁人群的新冠病毒第二剂加强疫苗接种 - 美国，2021年8月13日至2022年8月5日
MMWR Morb Mortal Wkly Rep. 2022 Sep 2;71(35):1121-1125. doi: 10.15585/mmwr.mm7135a4.
2
Booster and Additional Primary Dose COVID-19 Vaccinations Among Adults Aged ≥65 Years - United States, August 13, 2021-November 19, 2021.≥65 岁成年人的 COVID-19 疫苗加强针和额外初级剂量接种-美国，2021 年 8 月 13 日-2021 年 11 月 19 日。
MMWR Morb Mortal Wkly Rep. 2021 Dec 17;70(50):1735-1739. doi: 10.15585/mmwr.mm7050e2.
3
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.在德尔塔和奥密克戎变异株流行期间，mRNA 疫苗加强针在成年人中的 COVID-19 相关急诊和紧急护理就诊和住院方面的效果 - VISION 网络，10 个州，2021 年 8 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 21;71(4):139-145. doi: 10.15585/mmwr.mm7104e3.
4
Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status - United States, January 12, 2022-March 28, 2022.2022 年 1 月 12 日至 2022 年 3 月 28 日期间，针对疑似免疫功能低下的≥12 岁人群接种 COVID-19 mRNA 疫苗加强针的安全性监测-美国。
MMWR Morb Mortal Wkly Rep. 2022 Jul 15;71(28):899-903. doi: 10.15585/mmwr.mm7128a3.
5
The Advisory Committee on Immunization Practices' Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines - United States, 2021.免疫实践咨询委员会关于 COVID-19 疫苗加强针和额外基础针的临时建议-美国，2021 年。
MMWR Morb Mortal Wkly Rep. 2021 Nov 5;70(44):1545-1552. doi: 10.15585/mmwr.mm7044e2.
6
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults - United States, September 22, 2021-February 6, 2022.COVID-19 疫苗加强针接种后的安全性监测-美国，2021 年 9 月 22 日-2022 年 2 月 6 日。
MMWR Morb Mortal Wkly Rep. 2022 Feb 18;71(7):249-254. doi: 10.15585/mmwr.mm7107e1.
7
COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022.COVID-19 相关住院病例在 SARS-CoV-2 德尔塔和奥密克戎变异株流行期间的种族/民族差异和疫苗接种状况分析——COVID-NET，14 个州，2021 年 7 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Mar 25;71(12):466-473. doi: 10.15585/mmwr.mm7112e2.
8
In brief: Booster doses of mRNA-based COVID-19 vaccines for all adults.简而言之：为所有成年人接种基于mRNA的新冠病毒疫苗加强针。
Med Lett Drugs Ther. 2021 Dec 27;63(1640):201-202.
9
Disparities in COVID-19 Vaccine Booster Uptake in the USA: December 2021-February 2022.2021年12月至2022年2月美国新冠疫苗加强针接种情况的差异
J Gen Intern Med. 2022 Aug;37(11):2918-2921. doi: 10.1007/s11606-022-07648-5. Epub 2022 May 24.
10
COVID-19 Vaccination Coverage Among Adults - United States, December 14, 2020-May 22, 2021.COVID-19 疫苗接种覆盖情况在成年人中 - 美国，2020 年 12 月 14 日-2021 年 5 月 22 日。
MMWR Morb Mortal Wkly Rep. 2021 Jun 25;70(25):922-927. doi: 10.15585/mmwr.mm7025e1.
引用本文的文献
1
Multidimensional Demographic Analyses of COVID-19 Vaccine Inequality in the United States: A Systematic Review.美国新冠疫苗不平等问题的多维人口分析：一项系统综述
Healthcare (Basel). 2025 Jan 13;13(2):139. doi: 10.3390/healthcare13020139.
2
Nirmatrelvir/Ritonavir Regimen for Mild/Moderately Severe COVID-19: A Rapid Review With Meta-Analysis and Trial Sequential Analysis.尼马瑞韦/利托那韦方案治疗轻/中度 COVID-19：一项快速综述，包括荟萃分析和试验序贯分析。
Ann Fam Med. 2024 Jul-Aug;22(4):336-346. doi: 10.1370/afm.3120.
3
Barriers to initial COVID-19 booster among US adults who completed a primary vaccine series in the CHASING COVID cohort, September 2021-October 2022.2021年9月至2022年10月在“追踪新冠”队列中完成初级疫苗接种系列的美国成年人首次接种新冠加强针的障碍
Am J Epidemiol. 2025 May 7;194(5):1341-1351. doi: 10.1093/aje/kwae209.
4
Reasons for COVID-19 Non-Vaccination from 2021 to 2023 for Adults, Adolescents, and Children.2021年至2023年成人、青少年和儿童未接种新冠疫苗的原因
Vaccines (Basel). 2024 May 22;12(6):568. doi: 10.3390/vaccines12060568.
5
Colocating Syringe Services, COVID-19 Vaccination, And Infectious Disease Testing: Baltimore's Experience.注射器服务、COVID-19 疫苗接种和传染病检测同址设置：巴尔的摩的经验。
Health Aff (Millwood). 2024 Jun;43(6):883-891. doi: 10.1377/hlthaff.2024.00032.
6
Protocol for a community-based digital storytelling pilot intervention to reduce Hispanic parents' vaccine hesitancy to immunize their children against COVID-19.基于社区的数字讲故事试点干预方案，以减少西班牙裔父母对接种 COVID-19 疫苗的犹豫。
PLoS One. 2024 Mar 19;19(3):e0299787. doi: 10.1371/journal.pone.0299787. eCollection 2024.
7
Social and demographic factors associated with receipt of a COVID-19 vaccine initial booster dose and with interval between primary series completion and initial booster dose uptake among persons aged ≥ 12 years, United States, August 2021-October 2022.与 COVID-19 疫苗初始加强针接种以及与≥12 岁人群在完成初级系列疫苗接种和初始加强针接种之间的间隔时间相关的社会人口因素，美国，2021 年 8 月-2022 年 10 月。
Vaccine. 2024 Apr 2;42(9):2122-2126. doi: 10.1016/j.vaccine.2024.02.089. Epub 2024 Mar 7.
8
Co-Administration of Influenza and COVID-19 Vaccines: Policy Review and Vaccination Coverage Trends in the European Union, UK, US, and Canada between 2019 and 2023.流感疫苗与新冠疫苗的联合接种：2019年至2023年欧盟、英国、美国和加拿大的政策审查与疫苗接种覆盖率趋势
Vaccines (Basel). 2024 Feb 19;12(2):216. doi: 10.3390/vaccines12020216.
9
Comparison of factors associated with seasonal influenza and COVID-19 booster vaccination coverage among healthcare personnel working at acute care hospitals during 2021-2022 influenza season, National Healthcare Safety Network, United States.2021 - 2022流感季期间美国国家医疗安全网络中，急性护理医院医护人员季节性流感和新冠病毒加强针疫苗接种覆盖率相关因素的比较
Prev Med. 2024 Feb;179:107852. doi: 10.1016/j.ypmed.2024.107852. Epub 2024 Jan 9.
10
Decreased Self-reported Physical Fitness Following SARS-CoV-2 Infection and the Impact of Vaccine Boosters in a Cohort Study.一项队列研究中SARS-CoV-2感染后自我报告的体能下降及疫苗加强针的影响
Open Forum Infect Dis. 2023 Nov 17;10(12):ofad579. doi: 10.1093/ofid/ofad579. eCollection 2023 Dec.
本文引用的文献
1
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022.2、3 和 4 剂 COVID-19 mRNA 疫苗在 SARS-CoV-2 奥密克戎 BA.1 和 BA.2/BA.2.12.1 亚谱系占主导地位期间对免疫功能正常成年人的有效性 - VISION 网络，10 个州，2021 年 12 月至 2022 年 6 月。
MMWR Morb Mortal Wkly Rep. 2022 Jul 22;71(29):931-939. doi: 10.15585/mmwr.mm7129e1.
2
Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.在奥密克戎毒株占主导期间，既往BNT162b2型新冠疫苗接种与儿童及青少年有症状的新冠病毒感染之间的关联
JAMA. 2022 Jun 14;327(22):2210-2219. doi: 10.1001/jama.2022.7493.
3
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.mRNA COVID-19 疫苗 3 剂接种与 SARS-CoV-2 奥密克戎和德尔塔变异株引起的有症状感染之间的关联。
JAMA. 2022 Feb 15;327(7):639-651. doi: 10.1001/jama.2022.0470.
4
Rural and Urban Differences in COVID-19 Prevention Behaviors.农村和城市 COVID-19 预防行为的差异。
J Rural Health. 2021 Mar;37(2):287-295. doi: 10.1111/jrh.12556. Epub 2021 Feb 22.
Zotero 插件